Literature DB >> 21824455

Late-life health consequences of exposure to trauma in a general elderly population: the mediating role of reexperiencing posttraumatic symptoms.

Isabelle Chaudieu1, Joanna Norton, Karen Ritchie, Philippe Birmes, Guillaume Vaiva, Marie-Laure Ancelin.   

Abstract

OBJECTIVE: A history of trauma is associated with poor mental and physical health, but the specific impact of posttraumatic stress disorder (PTSD) symptoms on physical health using objective indicators of health status has rarely been evaluated in elderly civilians. This study investigates the long-term consequences of a lifetime exposure to trauma on health in a French elderly general population.
METHOD: Data from this retrospective study were derived from a longitudinal study (the Enquête de Santé Psychologique-Risques, Incidence et Traitement [ESPRIT]) of community-dwelling participants. Psychiatric health, medical history, and clinical examination (ICD-10 criteria) were assessed in 1,662 subjects (mean [SD] age = 72.5 [5.2] years). Lifetime traumatic exposure, PTSD, and psychiatric diagnoses were obtained using the Watson PTSD Inventory and the Mini-International Neuropsychiatric Interview. The outcome measures used were the Mini-International Neuropsychiatric Interview, Center for Epidemiologic Studies Depression Scale, Mini-Mental State Examination, and measures of physical health.
RESULTS: We observed an increase in the number and severity of health-related outcomes between groups, with nontraumatized subjects having the lowest risk and those with trauma leading to recurrent reexperiencing of events (nonresilient subjects) having the highest risk. Traumatized persons who did not report reexperiencing symptoms (resilient subjects) showed better current mental health than traumatized subjects who did and nontraumatized subjects. Nonresilient subjects were more likely to have current depressive symptoms (P = .003), current major depression (P < .0001), current anxiety disorder (P = .032), and psychiatric comorbidity (P = .002) than nontraumatized subjects. Resilient subjects differed from nontraumatized subjects in having significantly less current suicidal ideation (P = .054) and psychiatric comorbidity (P = .035). Both groups of traumatized subjects showed a higher rate of cardio-ischemic diseases, notably current angina pectoris (multivariate, adjusted OR = 2.27; 95% CI, 1.31-3.91; and OR = 2.34; 95% CI, 1.22-4.49; for resilient and nonresilient groups, respectively). Traumatized persons, specifically those nonresilient, showed a higher waist-hip ratio, higher triglyceride levels, and a greater frequency of hypertension.
CONCLUSIONS: Our findings suggest that trauma could be associated with cardio-ischemic diseases independently of PTSD symptoms expression. However, the presence of these symptoms appears associated with additional metabolic risk factors. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21824455     DOI: 10.4088/JCP.10m06230

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

1.  Posttraumatic Stress Disorder Among Older Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Man Cheung Chung; Rupert C M Jones; Sam A Harding; John Campbell
Journal:  Psychiatr Q       Date:  2016-12

Review 2.  Psychosocial risk factors for hypertension: an update of the literature.

Authors:  Yendelela Cuffee; Chinwe Ogedegbe; Natasha J Williams; Gbenga Ogedegbe; Antoinette Schoenthaler
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

3.  Chronic and remitting trajectories of depressive symptoms in the elderly. Characterisation and risk factors.

Authors:  I Carrière; A Farré; C Proust-Lima; J Ryan; M L Ancelin; K Ritchie
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-15       Impact factor: 6.892

4.  Measures of adult psychological resilience following early-life adversity: how congruent are different measures?

Authors:  Kristen Nishimi; Karmel W Choi; Janine Cerutti; Abigail Powers; Bekh Bradley; Erin C Dunn
Journal:  Psychol Med       Date:  2020-05-14       Impact factor: 7.723

5.  Measuring resilience in adult women using the 10-items Connor-Davidson Resilience Scale (CD-RISC). Role of trauma exposure and anxiety disorders.

Authors:  Jacqueline Scali; Catherine Gandubert; Karen Ritchie; Maryvonne Soulier; Marie-Laure Ancelin; Isabelle Chaudieu
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Psychological resilience predicting cardiometabolic conditions in adulthood in the Midlife in the United States Study.

Authors:  Kristen M Nishimi; Karestan C Koenen; Brent A Coull; Ruijia Chen; Laura D Kubzansky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 12.779

7.  The effect of an adverse psychological environment on salivary cortisol levels in the elderly differs by 5-HTTLPR genotype.

Authors:  Marie-Laure Ancelin; Jacqueline Scali; Joanna Norton; Karen Ritchie; Anne-Marie Dupuy; Isabelle Chaudieu; Joanne Ryan
Journal:  Neurobiol Stress       Date:  2017-03-22

8.  Handgrip Strength of World Trade Center (WTC) Responders: The Role of Re-Experiencing Posttraumatic Stress Disorder (PTSD) Symptoms.

Authors:  Soumyadeep Mukherjee; Sean Clouston; Roman Kotov; Evelyn Bromet; Benjamin Luft
Journal:  Int J Environ Res Public Health       Date:  2019-03-29       Impact factor: 3.390

9.  Influence of personal and environmental factors on mental health in a sample of Austrian survivors of World War II with regard to PTSD: is it resilience?

Authors:  Ulrich S Tran; Tobias M Glück; Brigitte Lueger-Schuster
Journal:  BMC Psychiatry       Date:  2013-02-04       Impact factor: 3.630

10.  Structural brain changes with lifetime trauma and re-experiencing symptoms is 5-HTTLPR genotype-dependent.

Authors:  Marie-Laure Ancelin; Isabelle Carriere; Sylvaine Artero; Jerome J Maller; Chantal Meslin; Anne-Marie Dupuy; Karen Ritchie; Joanne Ryan; Isabelle Chaudieu
Journal:  Eur J Psychotraumatol       Date:  2020-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.